Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Robotic Vascularized Composite Bladder Allograft Transplantation: A Phase 0 (First-in-Human), Single Institutional Study for Deceased-Donor Bladder Transplantation

NCT05462561 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT05462561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05462561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Robotic Vascularized Composite Bladder Allograft Transplantation: A Phase 0 (First-in-Human), Single Institutional Study for Deceased-Donor Bladder Transplantation
Lead sponsor
University of Southern California
Phase
Not applicable
Overall status
Suspended
Start date
May 1, 2023
Completion date
October 3, 2028
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder dysfunction, immunosuppression, neurogenic bladder